Switching hinges on changing behaviour

15 September 2015 - Deborah Wilkes

Changing the behaviour of key stakeholders – including consumers, healthcare professionals and regulators – lies at the heart of any successful switch of a medicine from prescription to non-prescription status. Companies should also be prepared to rethink their own behaviour and expectations.